Immunomodulation for the management of corona virus disease (COVID-19)

Affiliations

¹ Dept. Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720-3220, United States. Electronic address: dkiprovcai@aol.com.
² Dept. Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720-3220, United States. Electronic address: conboymj@berkeley.edu.
³ Dept. Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720-3220, United States. Electronic address: iconboy@berkeley.edu.

Comment

Dobri Kiprov et al. Transfus Apher Sci. 2020 Aug.

. 2020 Aug;59(4):102856.

doi: 10.1016/j.transci.2020.102856. Epub 2020 Jun 27.

¹ Dept. Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720-3220, United States. Electronic address: dkiprovcai@aol.com.
² Dept. Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720-3220, United States. Electronic address: conboymj@berkeley.edu.
³ Dept. Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720-3220, United States. Electronic address: iconboy@berkeley.edu.

No abstract available

Comment on

Deployment of convalescent plasma for the prevention and treatment of COVID-19.
Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Bloch EM, et al. J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745. J Clin Invest. 2020. PMID: 32254064 Free PMC article. Review.

1. Bloch E.M., Bailey J.A., Tobian Aaron A.R. Deployment of convalescent plasma for the prevention and treatment of COVID-19. Review in press preview COVID-19. J Clin Invest. 2020 doi: 10.1172/JCI138745. - DOI - PMC - PubMed
1. Koff W.C., Williams Michelle A. Covid-19 and immunity in aging populations — a new research agenda. N Engl J Med. 2020;(April 17) doi: 10.1056/NEJMp2006761. - DOI - PubMed
1. Rebo J., Mehdipour M., Conboy I.M. A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood. Nat Commun. 2016;22(November (7)):13363. PMID:27874859. - PMC - PubMed
1. Kiprov D. Intermittent heterochronic plasma exchange as a modality for delaying cellular senescence – a hypothesis. J Clin Apheresis. 2013;28:387–389. - PubMed
1. Keith P., Day M., Perkins L., Moyer L., Hewitt K., Wells A. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19. Crit Care. 2020;24:128. doi: 10.1186/s13054-020-2836-4. - DOI - PMC - PubMed